Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Org 4419-2 for obstructive sleep apnea/hypopnea syndrome
2005-000733-37Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obstructive sleep apnea hypopnea syndrome (OSAHS) comparing Org 4419-2 with Placebo (2 arms). Primary endpoint: Change from baseline in Apnea Hypopnea Index at Day 28. Started Jun 2005; status: completed.
02
Drugs
mirtazapine
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on 2005-000733-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000733-37.